or Try an Advanced Search...

    Clinical Trial Stocks List

    Symbol Grade Name % Change
    OMER A Omeros Corporation 28.19
    AKRO B Akero Therapeutics, Inc. 1.84
    SUPN C Supernus Pharmaceuticals, Inc. -0.83
    OPK C OPKO Health Inc. -1.27
    CARA D Cara Therapeutics, Inc. 1.64
    GLYC D GlycoMimetics, Inc. -3.03
    OCUL D Ocular Therapeutix, Inc. -2.96
    EXAI D Exscientia Limited 0.00
    HCM D Hutchison China MediTech Limited -1.56
    ICLR D ICON plc 4.46
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Autoimmune Disease Biotechnology Clinical Research Acute Myeloid Leukemia Advanced Solid Tumors Biopharmaceutical Development Cancer Central Nervous System Disease Clinical Development Clinical Pharmacology Compugen Drug Discovery Hematological Cancers Infarction Infectious Diseases Inflammatory Bowel Disease Life Sciences Lymphoma Myocardial Infarction Nerve

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial stocks.

    Symbol Grade Name Weight
    TXSS A Texas Small Cap Equity Index ETF 0.04
    RFLR B Innovator U.S. Small Cap Power Buffer ETF - September Innovator U.S. Small Cap Managed Floor ETF 0.02
    VTWO B Vanguard Russell 2000 ETF 0.01
    IWC B iShares Microcap ETF 0.01
    VTI A Vanguard Total Stock Market ETF 0.0
    View all Clinical Trial ETFs...
    Compare ETFs
    Compare IWC to VTI Compare RFLR to VTI Compare TXSS to VTWO

        Clinical Trial Stocks Recent News

        Date Stock Title
        Nov 21 ICLR Should You Retain Your Conviction in Icon Plc (ICLR)?
        Nov 21 OMER Omeros Corporation Provides Update on Progress Toward BLA Resubmission
        Nov 21 ICLR Baird cuts Icon target, names ‘Bullish Fresh Pick’
        Nov 20 OPK OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
        Nov 20 EXAI Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
        Nov 18 AKRO Akero a new buy at Citi on liver disease asset
        Nov 18 OPK NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
        Nov 17 CARA Cara Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 OMER Omeros Q3 2024 - Updates On OMIDRIA And Narsoplimab Lead To Liquidity Concerns
        Nov 16 OPK Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
        Nov 15 ICLR ICON Public Limited Company (ICLR): Among 12 High Growth Large Cap Stocks to Buy Now
        Nov 15 AKRO Akero Therapeutics to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at 75th Annual AASLD The Liver Meeting® 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biotechnology Clinical Research Drug Discovery Medicine Biomarkers Biopharmaceutical Cataracts Chemotherapy Clinical Pharmacology Clinical Trial Product Inflammation Non Small Cell Lung Cancer Nursing Research Pain Pharmaceutical Product Testing Small Cell Lung Cancer Active Pharmaceutical Ingredients Acute And Chronic Pain Acute Myeloid Leukemia
        Clinical Trial

        A clinical trial is a research study in which people volunteer to test new treatments, interventions, or tests as a means to prevent, detect, or treat diseases or conditions. Clinical trials are conducted to determine the safety and effectiveness of new drugs, medical devices, or other treatments.

        Browse All Tags